VUNO
About VUNO
VUNO is a leading South Korean healthcare AI company specializing in the development and commercialization of advanced deep learning-based medical solutions. The company leverages artificial intelligence to analyze a wide array of medical data, including bio-signals, medical imaging (such as X-rays, CT scans, fundus images, and MRIs), and digital pathology. Their clinically proven solutions are designed to enhance diagnostic accuracy, facilitate early disease detection, and predict critical health events, thereby improving patient outcomes and streamlining clinical workflows for healthcare professionals.
VUNO’s product portfolio, under the ‘VUNO Med’ brand, includes solutions like VUNO Med-Chest X-ray for detecting lung abnormalities, VUNO Med-DeepBrain for quantifying brain atrophy in neurodegenerative diseases, VUNO Med-Fundus AI for assessing retinal images, and VUNO Med-DeepCARS for predicting in-hospital cardiac arrest using vital signs. While they previously offered VUNO Med-BoneAge for bone age assessment, the company strategically divested this business to focus on areas with higher growth potential, particularly preventive healthcare and biosignal-based AI solutions.
Committed to patient-centric innovation, VUNO aims to address medical ambiguities and complexities through AI technology, making high-quality healthcare more accessible globally. Their solutions are designed to integrate seamlessly into existing clinical environments, providing valuable decision support tools that help medical professionals save time, reduce costs, and deliver more precise care.
Focus Areas
Business Intelligence
| Key Investors | SBI Investment Korea, Smilegate Investment, HB Investment, FuturePlay, BonAngels Venture Partners, Pathway Investment |
| Partnerships | Centaur Labs (for FDA annotation services), Contextflow, European hospitals (for DeepCARS pilot tests), U.S. hospital systems (for market entry) |
| Acquisitions | None (has divested certain product lines, including VUNO Med-BoneAge to Maihub and Chest CT AI business to Coreline Soft) |
| Technology | Deep learning-based AI solutions, AI-driven medical solutions, analyzes medical imaging (2D & 3D), biosignals (vital signs, ECG), and medical speech recognition |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
VUNO's AI solutions are designed to significantly enhance clinical workflows and diagnostic accuracy for physicians. They offer faster and more consistent analysis of medical images and biosignals, reducing the burden of manual interpretation and improving efficiency. For instance, VUNO Med-DeepBrainu2122 can analyze brain MRIs in minutes, providing critical data for early dementia diagnosis. VUNO Med-DeepCARSu2122 provides early warnings for cardiac arrest, allowing for timely intervention and potentially improving patient outcomes. The solutions are clinically validated and have received various regulatory approvals (MFDS, CE Mark, FDA), providing confidence in their reliability. By automating routine tasks and providing objective data, VUNO's AI empowers physicians to focus on complex cases and deliver higher quality, patient-centric care.
VUNO's AI solutions are built for seamless integration into existing healthcare IT infrastructure. They are designed to be agnostic to specific devices and environments, offering compatibility with Picture Archiving and Communication Systems (PACS) and Electronic Medical Record (EMR) systems. This flexibility allows for easy adoption and minimizes disruption to current clinical workflows, whether through cloud-based services or on-premise installations.
What the Web Says
VUNO is a South Korean medical AI company specializing in AI-powered diagnostic support solutions for various medical fields, including cardiology, neurology, and ophthalmology. They have achieved significant milestones, including multiple breakthrough device designations in South Korea and FDA clearance in the US for some of their products. Ventuno Technologies, a separate entity, focuses on providing a comprehensive platform for managing, distributing, and monetizing video content for broadcasters and OTT service providers.
Overall: MixedStrengths
- VUNO's AI solutions improve diagnostic accuracy and efficiency for medical professionals.
- VUNO's products, like VUNO Med-DeepCARS, help identify high-risk patients and lighten healthcare staff workload.
- VUNO has received positive feedback for its AI solutions and government support in the healthcare industry.
- Ventuno Technologies is described as inexpensive and problem-solving oriented for CTV and mobile VOD apps.
- Ventuno Technologies offers a ready-to-help customer care team, available almost 24 hours.
- Ventuno Technologies is easy to use and user-friendly, with all options available for OTT platform development.
Limitations
- Ventuno Technologies takes a long time to refresh CMS playlists.
- Ventuno Technologies' payment options need improvement for easier payment.
- There are not enough reviews for Ventuno Technologies on G2 to provide comprehensive buying insight.
- Some similarly named companies (e.g., Veyluno, VionB) have been associated with scams or low-quality products.
- Uno Health, another similarly named company, has very negative employee reviews regarding management, job security, and work-life balance.
Based on reviews from: G2, BioWorld, PitchBook, The Worldfolio, VUNO Official Website, KBR, Trustpilot, Capterra, Reddit, Indeed.com
Last updated: 2026-07-20
Videos
News, demos, and interviews about VUNO.
Videos load interactively. If none appear, search YouTube for VUNO →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]